compulsory licensing

com·pul·so·ry li·cens·ing

(kŏm-pŭl'sŏr-ē lī'sĕns-ing)
An imprecise term intended to denote any occupation or business that requires the participant or professional to gain or acquire approval from a regulatory body before such person may pursue such occupation within any given jurisdiction.
Mentioned in ?
References in periodicals archive ?
A stormy discussion in the media and in society has recently evoked several topics - the future methodology for pricing medicines, compulsory licensing and parallel imports.
The compulsory licensing provision was proposed to be implemented immediately, pending establishment of the EMPP system, with the systems thereafter integrated.
Ever since India used the compulsory licensing provision for a cancer drug, multinational pharma companies have been trying to get the government to commit to a no-use doctrine that UPA and NDA have so far resisted.
Compulsory licensing is enabled under four sections of the Indian Patents Act.
Insufficient Royalty Payments under Compulsory Licensing B.
Because of its potentially significant implications for consumer welfare, compulsory licensing is one of the most controversial topics in intellectual property policy today.
US companies assert that the fear of compulsory licensing is the primary reason why they are reluctant to launch new drugs in India.
Compulsory licensing on frivolous grounds can entail litigations, which could eventually lead to it being revoked.
Now, Aereo says that if that's the case, it should be allowed to retransmit signals under what's called a compulsory licensing arrangement.
Compulsory licensing of patents has been provided under TRIPS Agreement as a legitimate safeguard to check abuse of monopoly and to deal with special situations of public health crisis.
She examines this approach in the context of international trade and health (especially the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), the Agreement on the Application of Sanitary and Phytosanitary Measures, and the Agreement on Technical Barriers to Trade regimes), suggesting that a safety factor based on the precautionary approach can be accommodated into the TRIPS agreement to promote access to health technologies and address the dilemma of access to medicines during a public health emergency, particularly in the compulsory licensing provision of the agreement.

Full browser ?